These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2361839)

  • 41. A ten year study of partial mastectomy for carcinoma of the breast.
    Stehlin JS; de Ipolyi PD; Greeff PJ; Gutierrez AE; Hardy RJ; Dahiya SL
    Surg Gynecol Obstet; 1987 Sep; 165(3):191-8. PubMed ID: 3629435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Clinical characteristics and prognostic factors of female breast cancer patients with 10 or more positive lymph nodes: a report of 128 patients].
    Guan Y; Xu BH; Li Q; Zhang P; Zhao LM; Yuan P; Wang JY
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):77-81. PubMed ID: 18353207
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Postoperative loco-regional radiation therapy for breast cancer patients with four or more involved lymph nodes or extracapsular extension.
    Evron E; Barzily L; Rakowsky E; Ben-Baruch N; Sulkes J; Rizel S; Fenig E
    Isr Med Assoc J; 2005 Jul; 7(7):439-42. PubMed ID: 16011059
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A randomized trial of long term adjuvant tamoxifen plus postoperative radiation therapy versus radiation therapy alone for patients with early stage breast carcinoma treated with breast-conserving surgery. Stockholm Breast Cancer Study Group.
    Dalberg K; Johansson H; Johansson U; Rutqvist LE
    Cancer; 1998 Jun; 82(11):2204-11. PubMed ID: 9610700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A candidate molecular signature associated with tamoxifen failure in primary breast cancer.
    Vendrell JA; Robertson KE; Ravel P; Bray SE; Bajard A; Purdie CA; Nguyen C; Hadad SM; Bieche I; Chabaud S; Bachelot T; Thompson AM; Cohen PA
    Breast Cancer Res; 2008; 10(5):R88. PubMed ID: 18928543
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of margins on ipsilateral breast tumor recurrence after breast conservation therapy for lymph node-negative breast carcinoma.
    Leong C; Boyages J; Jayasinghe UW; Bilous M; Ung O; Chua B; Salisbury E; Wong AY
    Cancer; 2004 May; 100(9):1823-32. PubMed ID: 15112262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Segmental mastectomy and tamoxifen alone provide adequate locoregional control of breast cancer in elderly women.
    Yeh S; Tan LR; O'Connell TX
    Am Surg; 1997 Oct; 63(10):854-7. PubMed ID: 9322656
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adjuvant therapy of node-negative breast cancer.
    McGuire WL
    N Engl J Med; 1989 Feb; 320(8):525-7. PubMed ID: 2915655
    [No Abstract]   [Full Text] [Related]  

  • 50. [Adjuvant colchicine pharmaceuticals in the combined surgical treatment of breast cancer (author's transl)].
    Li SL; Liu L; Ma SZ; Li YY; Ning LS
    Zhonghua Zhong Liu Za Zhi; 1979; 1(3):212-5. PubMed ID: 553798
    [No Abstract]   [Full Text] [Related]  

  • 51. Adjuvant therapy for node-negative breast cancer.
    N Engl J Med; 1989 Aug; 321(7):469-73. PubMed ID: 2761581
    [No Abstract]   [Full Text] [Related]  

  • 52. Adjuvant tamoxifen in postmenopausal patients with breast cancer and negative axillary lymph nodes.
    Scholten C; Sevelda P; Kurz C; Salzer H; Kubista E; Staffen A; Czerwenka K; Spona J; Aiginger P; Zielinski CC
    Eur J Cancer; 1992; 28A(12):2083. PubMed ID: 1419306
    [No Abstract]   [Full Text] [Related]  

  • 53. [The postoperative care of operated breast carcinoma].
    Dtsch Med Wochenschr; 1991 Jul; 116(27):1077-9. PubMed ID: 2065592
    [No Abstract]   [Full Text] [Related]  

  • 54. Node negative breast cancer.
    O'Reilly SM; Richards MA
    BMJ; 1990 Feb; 300(6721):346-8. PubMed ID: 2106982
    [No Abstract]   [Full Text] [Related]  

  • 55. Breast cancer, tamoxifen, and surgery.
    Lancet; 1988 May; 1(8593):1044-5. PubMed ID: 2896881
    [No Abstract]   [Full Text] [Related]  

  • 56. [The aftercare of operated breast carcinoma].
    Maass H
    Dtsch Med Wochenschr; 1991 Mar; 116(9):355. PubMed ID: 1847677
    [No Abstract]   [Full Text] [Related]  

  • 57. Node-negative breast cancer: tamoxifen and chemosuppression.
    Jordan VC
    J Natl Cancer Inst; 1990 Jun; 82(12):1068-9. PubMed ID: 2348471
    [No Abstract]   [Full Text] [Related]  

  • 58. Adjuvant questions.
    Brinkley D
    Br Med J (Clin Res Ed); 1984 Jun; 288(6432):1709-10. PubMed ID: 6428507
    [No Abstract]   [Full Text] [Related]  

  • 59. Breast cancer and hormone replacement therapy.
    Lancet; 1990 Feb; 335(8684):297-8. PubMed ID: 1967758
    [No Abstract]   [Full Text] [Related]  

  • 60. Adjuvant therapy for node-negative breast cancer patients. Who benefits?
    Balch CM; Singletary SE
    Arch Surg; 1988 Oct; 123(10):1189-90. PubMed ID: 3178465
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.